Erik L. Ridley and Philip Ward[email protected]AIRadNet broadens AI focus with acquisitions of Aidence, QuantibImaging services provider RadNet has acquired Dutch artificial intelligence (AI) software developers Aidence and Quantib in deals that the company hopes will enable wide-scale screening programs for lung and prostate cancer.January 23, 2022Page 1 of 1Top StoriesWomens ImagingMore women welcome AI assistance for mammography examsMore women are willing to have AI assistance for their breast cancer screening exams.Molecular ImagingPET scans predict outcomes for patients undergoing CAR T-cell therapyCTAbdominal CT imaging shows potential for diagnosing sarcopeniaAIHow can AI best help in LDCT lung cancer screening?Molecular ImagingNew theranostics PET tracer shows promise